In cancer genome atlas data, genes mutated in luminal A, B, and basal such as breast cancer are listed, TP53, PIK3CA, MAP3K1, and PTEN, which are used as a therapeutic tool in triple negative breast cancer. This evidence concerns the gene TP53 and cancer.